AstraZeneca’s Executive Shakeup Includes Global Strategist To Be Named Later
This article was originally published in The Pink Sheet Daily
Executive Summary
AstraZeneca's new CEO Pascal Soriot signaled significant change is afoot for the troubled drug maker by eliminating the jobs of R&D President Martin Mackay and Exec VP-Global Commercial Tony Zook.